Autoimmunity to Ryanodine Receptor and Titin in Myasthenia Gravis is Associated with GM Allotypes

References

• Lindstrom J., Schelton D., Fujii Y. Myasthenia gravis. Adv. Immunol. 1988; 42: 233–284
   PubMed Web of Science ®Google Scholar
• Murphy J., Murphy S. F. Myasthenia gravis in identical twins. Neurology 1986; 36: 78–80
   PubMed Web of Science ®Google Scholar
• Bergoffen J., Zmijewski C. M., Fischbeck K. H. Familial autoimmune myasthenia gravis. Neurology 1994; A: 551–554
   Google Scholar
• Degli-Esposti M. A., Andreas A., Christiansen F. T., Schalke B., Albert E., Dawkins R. L. An approach to the localization of the susceptibility genes for generalized myasthenia gravis by mapping recombinant ancestral haplotypes. lmmunogenetics 1992; 35: 355–364
   PubMed Web of Science ®Google Scholar
• Marshall B., Leelayuwat C, Abraham L. J., Pinelli M., Dawkins R. L. Large transcripts and sequence from a polymorphic 170 kb MHC region implicated in susceptibility to autoimmune disease. lmmunogenetics 1994; 39: 15–20
   PubMed Web of Science ®Google Scholar
• Carlsson B., Wallin J., Pirskanen R., Matell G., Smith C. I. E. Different HLA DR-DQ associations in subgroups of idiopathic myasthena gravis. lmmunogenetics 1990; 31: 285–290
   PubMed Web of Science ®Google Scholar
• Spurkland A., Gilhus N. E., Rønningen K. S., Aarli J. A., Vartdal F. Myasthenia gravis patients with thymus hyperplasia and myasthenia gravis patients with thymoma display different HLA associations. Tissue Antigens 1991; 37: 90–93
   PubMed Web of Science ®Google Scholar
• Grubb R. Advances in human immunoglobulin allotypes. Exp. Clin. Immunogent. 1995; 12: 191–197
   PubMedGoogle Scholar
• Oxelius V. A., Carlsson A. M., Hammarstrøm L., Bjør-Kander J., Hanson L. A. Linkage of IgA deficiency to Gm allotypes; the influence of Gm allotypes on IgA-IgG subclass deficiency. Clin. Exp. Immunol 1995; 99: 211–215
   PubMed Web of Science ®Google Scholar
• Goldblatt D., Scadding G. K., Lund V. J., Wade A. M., Turner M. W., Pandey J. P. Association of Gm Allotypes with the antibody response to the outer membrane proteins of a common upper respiratory tract organism, moraxella catarrhalis. J. Immunol 1994; 153: 5316–5320
   PubMed Web of Science ®Google Scholar
• Nakao Y., Sasazuki T. Gm and disease. Handbook of Experimental Immunology, D. M. Weir, L. A. Herzenberg, C. Blackwell. Blackwell, Oxford 1986; 96. 1–96.10
   Google Scholar
• Compston A., Kellar-Wood H., Wood N. Multiple sclerosis. Baillieres Clin. Neurol. 1994; 3(2)353–371
   PubMedGoogle Scholar
• Dawkins R. Myasthenia gravis. Histocompatibility Testing, P. I. Teraski. UCLA Tissue Typing Laboratory, Los Angeles 1980; 662
   Google Scholar
• Nakao Y., Matsumoto H., Miyazaki T., Nishitani H., Ota K., Fujita T., Tsuji K. Gm allotypes in myasthenia gravis. Lancet 1980; I: 677–680
   Google Scholar
• SmithGrubb C. I. E.R., Hammarstrom L., Matell G. Gm allotypes in Swedich myasthenia gravis patients. J. Immunogenelics 1983; 10: 1–9
   PubMed Web of Science ®Google Scholar
• Smith C. I. E., Grubb R., Hammarstrom L., Pirska-Nen R. Gm allotypes in Finnish myasthenia gravis patients. Neumlogx 1984; 34: 1604–1605
   PubMed Web of Science ®Google Scholar
• Chiu H. C, de Lange G. G., Willcox N., Vincent A., Ncwsom-Davis J., Hsieh K. H., Hung T. P. Immunoglobulin allotypes in Caucasian and Chinese myasthenia gravis: differences from Japanese paiienls. J. Neurol. Neurosurg. Psychiatry 1988; 51: 214–217
   PubMed Web of Science ®Google Scholar
• Gilhus N. E., Pandeyl J. P., Gaarder P. I., Aarli J. A. Immunoglobulin Allotypes in myasthenia gravis patients with a thymoma. Autoimmunity 1990; 3: 299–305
   Web of Science ®Google Scholar
• Gautel M., Lakey A., Barlow P. D., Holmes Z., Scales S., Leonard K., Labeit S., Mygland A., Gilhus N. E., Aarli J. A. Titin antibodies in myasthenia gravis: identilication of a major immunogenic region of titin. Neurology 1993; 43: 1581–1585
   PubMed Web of Science ®Google Scholar
• Skeie G. O., Mygland A., Aarli J. A., Gilhus N. E. Titin antibodies in patients with late onset myasthenia gravis: clinical correlations. Autoimmunity 1995; 20: 99–104
   PubMed Web of Science ®Google Scholar
• Mygland A., Tysnes O. B., Matre R., Volpe P., Aarli J. A., Gilhus N. F. Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma. Ann. Neurol 1992; 32: 589–591
   PubMed Web of Science ®Google Scholar
• Wiebecke D. The incidence of Gm(l,2,3,5) and Inv(1) in the population of the federal republic of Germany. Humangenetik 1973; 18: 175–180
   PubMedGoogle Scholar
• Mygland A., Tysnes O. B., Aarli J. A., Flood P. R., Gilhus N. E. Myasthenia gravis patients with a thymoma have antibodies against a high molecular weight protein in sarcoplasmatic reticulum. J. Neuwimmunoi 1992; 37: 1–7
   PubMed Web of Science ®Google Scholar
• Gaarder P. I., Natvig J. B. Distribution of isotypic and allotypic human IgG antigens in non-human primates. J. Immunol 1974; 113: 635–644
   PubMed Web of Science ®Google Scholar
• Schanficld M. S., van Logheim E. Human immunoglobulin allotypes. Handbook of Experimental Immunology, D. M. Weir, L. A. Herzenberg, C. Blackwell. Blackwell, Oxford 1986; 94
   Google Scholar
• Guidelines for human gene nomenclature. An international system for human gene nomenclature (ISGN.1987). Cyto-genet. Cell Genet. 1987; 46: 11–28
   PubMedGoogle Scholar
• Natvig J. B. Gm(g), a new human gamma-globulin factor determined by a gene behaving as allele of Gm5 in Caucasians. Bibl. Haematol 1968; 29: 294–298
   PubMedGoogle Scholar
• Sarvas H., Rautonen N., Sipinen S., Makela O. IgG Subclasses of pneumococcal antibodies-effect on allotype G2m(n). Scand. J. Immunol 1989; 29: 229–237
   PubMed Web of Science ®Google Scholar
• Ambrosino D. M., Schiffman G., Gotschlich E. C, Schur P. H., Rosenberg G. A., DeLange G. G., van Logheim E., Siber G. R. Correlation between G2m(n) immunoglobulin allotype and human antibody response and susceptibility to polysaccharide encapsulated bacteria. J. Clin. Invest. 1985; 75: 1935–1942
   PubMed Web of Science ®Google Scholar
• Weiss J. B., Austin R. K., Schanfield M. S., Kag-Noff M. K. Gluten-sensitive eneropathy. Immunoglobulin G heavy-chain (Gm) allotypes and the immune response to wheat gliadin. J. Clin. Invest. 1983; 72: 96–101
   PubMed Web of Science ®Google Scholar
• Legrand L., Rivat-Perran L., Huttin C, Ling N. R., Richardson P. HLA-and Gm-linked genes affecting the degradation rate of antigens (Sheep red blood cells) endocytozed by macrophages. Hum. Immunol. 1982; 4: 1–13
   PubMed Web of Science ®Google Scholar
• Willcox N. Myasthenia gravis. Curr. Opin. Immunol 1993; 5: 910–917
   PubMed Web of Science ®Google Scholar
• Marx A., Osborn M., Tzartos S., Geuder K. I., Schalkc B., Nix W., Kirchner T., Miiller-Hermelink H. K. A striational muscle antigen and myasthenia gravis associated thymomas share an acetylcholine-receptor epitope. Dev. Immunol 1992; 2: 77–84
   PubMedGoogle Scholar
• Mygland A., Kuwajima G., Mikoshiba K., Tysnes O. B., Aarli J. A., Gilhus N. E. Thymomas express epitopes shared by the ryanodine receptor. J. Neuroim-munol 1995; 62: 79–83
   PubMed Web of Science ®Google Scholar
• Gilhus N. E., Willcox N., Harcourt G., Nagvekar N., Beeson D., Vincent A., Newsom-Davis J. Antigen presentation by thymoma epithelial cells from myasthenia gravis patients to potentially pathogenic T cells. J. Neuroimmunol 1995; 56: 65–76
   PubMed Web of Science ®Google Scholar
• Demaine A., Willcox N., Janer M., Welsh K., Newsom-Davis J. Immunoglobulin heavy chain gene associations in myasthenia gravis: new evidence for disease heterogeneity. J. Neurol 1992; 239: 53–56
   PubMed Web of Science ®Google Scholar
• Mygland A., Tysnes O. B., Aarli J. A., Matre R., Gilhus N. E. IgG subclass distribution of ryanodine receptor autoantibodies in patients with myasthenia gravis and thymoma. J. Autoimmunity 1993; 6: 507–515
   PubMed Web of Science ®Google Scholar
• Morell A., Skvaril F., Steinberg A. G., van Logheim E., Terry W. D. Correlations between the concen trations of the four subclasses of IgG and Gm allotypes in normal human sera. J. Immunol 1972; 108: 195–206
   PubMed Web of Science ®Google Scholar
• Oxelius V. A. Serum IgG and IgG subclass contents in different Gm phenotypes. Scand. J. Immunol 1993; 37: 149–153
   PubMed Web of Science ®Google Scholar
• Pandey J. P., French A. H. GM phenotypes influence the concentrations of the four subclasses of IgG in normal human serum. Hum. Immunology 1996, (In press)
   PubMed Web of Science ®Google Scholar
• Mygland A., Aarli J. A., Matre R., Gilhus N. E. Ryanodine receptor antibodies related to severity of thymoma-associated myasthenia gravis. J. Neurol. Neurosurg. Psychiatry 1994; 57: 843–846
   PubMed Web of Science ®Google Scholar
• Skeie G. O., Bartoccioni E., Evoli A., Aarli J. A., Gilhus N. E. Ryanodine receptor antibodies are associated with severe myasthenia gravis. Eur. J. Neurol 1996; 3: 136–140
   Web of Science ®Google Scholar
• Mathiesen T., Persson M. A. A., Sundquist V. A., Wahren B. Neutralization capacity and antibody dependent cell mediated cytotoxity of separated IgG subclasses 1,3 and 4 against herpes simplex virus. Clin. Exp. Immunol 1988; 72: 211–215
   PubMedGoogle Scholar
• Rodgaard A., Nielsen F. C, Djurup R., Somnier F., Gammeltoft S. Acetylcholine receptor antibody in myasthenia gravis: predominance of IgG subclasses 1 and 3. Clin. Exp. Immunol 1987; 67: 82–88
   PubMed Web of Science ®Google Scholar